https://mugglehead.com/amylyx-pharmaceuticals-avexitide-lucidity-phase-3-results/ Mugglehead Media en 2026-11-14T17:35:02.592Z Amylyx Pharmaceuticals details 55% hypoglycemia reduction in Phase 3 NASDAQ: AMLX, NASDAQ: RZLT, NYSEARCA: XBI, Amylyx Pharmaceuticals, Rezolute, State Street SPDR S&P Biotech ETF, Phase 3, Post-bariatric hypoglycemia, Avexitide, FDA https://mugglehead.com/bitdeer-bitcoin-sales-november-13-2026/ Mugglehead Media en 2026-11-14T14:53:48.892Z Bitdeer reports 256.1 BTC in weekly sales and zero pure holdings NASDAQ: BTDR, TSE: HIVE, NASDAQ: HIVE, Bitdeer Technologies Group, HIVE Digital Technologies, Bitcoin mining, Bitcoin sales, AI infrastructure, Liquidity https://mugglehead.com/fermi-hyperscaler-prepayment-texas-power-development/ Mugglehead Media en 2026-11-13T21:49:41.013Z Fermi signs US$200M prepayment agreement for 600 MW Texas development NASDAQ: FRMI, LON: FRMI, NASDAQ: AMZN, Fermi Inc, Amazon.com Inc, Power supply, Data centres, Customer financing, Texas https://mugglehead.com/tandem-diabetes-care-mobi-tubeless-fda-clearance-seven-day-wear/ Mugglehead Media en 2026-11-13T15:22:09.286Z Tandem Diabetes Care wins FDA clearance for tubeless Mobi set worn up to 7 days NASDAQ: TNDM, NASDAQ: PODD, NASDAQ: MMED, Tandem Diabetes Care, Insulet Corporation, MiniMed Group Inc, Diabetes, Insulin pumps, FDA clearance, Medical devices https://mugglehead.com/novo-nordisk-etavopivat-sickle-cell-fda-ema-submissions/ Mugglehead Media en 2026-11-13T15:07:09.709Z Novo Nordisk seeks US and EU approval for sickle cell drug etavopivat CPH: NOVO-B, NYSE: NVO, NASDAQ: AGIO, Novo Nordisk, Agios Pharmaceuticals, Sickle cell disease, Etavopivat, Phase 3, Drug applications https://mugglehead.com/allarity-therapeutics-liability-settlement-earnings-guidance/ Mugglehead Media en 2026-11-13T14:48:06.264Z Allarity Therapeutics settles US$4.9M liability for US$1M NASDAQ: ALLR, NASDAQ: BDTX, Allarity Therapeutics, Black Diamond Therapeutics, Debt settlement, Earnings, Oncology, Clinical trials, NYSEARCA: XBI, State Street SPDR S&P Biotech ETF https://mugglehead.com/twenty-one-capital-third-quarter-bitcoin-gain-cash-debt/ Mugglehead Media en 2026-11-13T14:37:09.706Z Twenty One Capital reports US$1.09B bitcoin gain and US$102.8M cash NYSE: XXI, NASDAQ: NAKA, Twenty One Capital, Nakamoto Inc, Bitcoin treasury, Quarterly results, Liquidity, Convertible debt https://mugglehead.com/northern-graphite-sprott-debt-stream-restructuring/ Mugglehead Media en 2026-11-13T14:22:09.235Z Northern Graphite clears US$23.6M debt in Sprott restructuring CVE: NGC, OTCMKTS: NGPHF, FRA: 0NG, Northern Graphite Corporation, Graphite, Debt restructuring, Streaming, Namibia, Quebec https://mugglehead.com/digi-power-x-third-quarter-ai-revenue-columbiana-financing/ Mugglehead Media en 2026-11-13T14:01:14.126Z Digi Power X reports US$12.25M revenue as AI sales reach US$5.66M NASDAQ: DGXX, Digi Power X, AI infrastructure, Data centres, Quarterly results, Project financing https://mugglehead.com/cerrado-gold-manantial-espejo-acquisition-restart/ Mugglehead Media en 2026-11-13T13:52:09.050Z Cerrado Gold reports US$20M Manantial Espejo mine purchase CVE: CERT, OTCMKTS: CRDOF, TSE: PAAS, NYSE: PAAS, Cerrado Gold, Pan American Silver, Gold, Silver, Mine acquisitions, Argentina https://mugglehead.com/milestone-pharmaceuticals-cost-cuts-cash-runway-afib-trial/ Mugglehead Media en 2026-11-13T13:41:13.590Z Milestone Pharmaceuticals plans 30% expense cut to extend cash runway NASDAQ: MIST, Milestone Pharmaceuticals, Cardiovascular disease, Cost reductions, Phase 3, Cash runway https://mugglehead.com/nakamoto-kraken-loan-maturity-bitcoin-collateral/ Mugglehead Media en 2026-11-13T13:32:11.603Z Nakamoto extends maturity on 60M USDT of Kraken debt to December 2027 NASDAQ: NAKA, Nakamoto Inc, Bitcoin treasury, Debt refinancing, Collateral, Liquidity https://mugglehead.com/silver-valley-metals-cancels-private-placement/ Mugglehead Media en 2026-11-13T13:22:09.091Z Silver Valley Metals cancels C$2.4M private placement CVE: SILV, OTCMKTS: SVMFF, Silver Valley Metals, Lithium, Potash, Financing, Mexico https://mugglehead.com/americas-gold-silver-third-quarter-production-costs-cash/ Mugglehead Media en 2026-11-13T13:03:26.078Z Americas Gold and Silver reports record output as Q3 costs rise TSE: USA, NYSEAMERICAN: USAS, TSE: AYA, NASDAQ: AYA, Americas Gold and Silver Corporation, Aya Gold & Silver Inc., Silver, Quarterly results, Mexico, Idaho https://mugglehead.com/rezolute-uplift-tumor-hyperinsulinism-phase-3-results/ Mugglehead Media en 2026-11-13T12:52:08.987Z Rezolute reports 13 responders in preliminary Phase 3 tumor study NASDAQ: RZLT, NASDAQ: MIRM, NYSEARCA: XBI, Rezolute, Mirum Pharmaceuticals, State Street SPDR S&P Biotech ETF, Hyperinsulinism, Phase 3, Ersodetug, FDA https://mugglehead.com/avax-one-alberta-data-centre-avalanche-treasury/ Mugglehead Media en 2026-11-13T12:38:33.252Z AVAX One drops Alberta data-centre plan to focus on AVAX treasury NASDAQ: AVX, NASDAQ: BTBT, AVAX One Technology, Bit Digital, Avalanche, Digital asset treasuries, Staking, Data centres https://mugglehead.com/kennametal-india-quarterly-profit-hard-metal-sales/ Mugglehead Media en 2026-11-13T12:29:08.719Z Kennametal India reports ₹1.43B pretax profit as hard-metal sales climb NSE: KENNAMET, BOM: 505890, NYSE: KMT, Kennametal India Limited, Kennametal Inc., Tungsten, Hard metals, Earnings, India https://mugglehead.com/usgs-tungsten-critical-minerals-capacity-outlook-2030/ Mugglehead Media en 2026-11-12T19:36:24.335Z USGS projects tungsten capacity growth of at least 10 per cent by 2030 NASDAQ: ALM, FRA: ALI1, LON: TUN, Almonty Industries, Tungsten West, Tungsten, Critical minerals, Graphite, Production capacity